Notably, although CD8+ T cells serve as key effector cells in antitumor immunity, the GBM microenvironment is dominated by immunosuppressive cell populations (e.g., tumor-associated macrophages, microglia, and myeloid-derived suppressor cells) [10,52]. This evidence concerns the gene CD8A and glioblastoma.